scholarly journals The Relationship of Body Mass Index and Diabetic Foot Risk in Type 2 Diabetes Mellitus at Royal Prima Hospital on Period 2018 to 2020

2021 ◽  
Vol 2 (4) ◽  
pp. 201-205
Author(s):  
Emori Christina Simarmata ◽  
Tasya Armadinah ◽  
Yeni Puspawani ◽  
Juliana Lina

Body mass index (BMI) is a simple method that is commonly used to determine whether a person is obese or not.  Diabetes mellitus is a disorder of the metabolic system because the pancreas cannot produce enough insulin or the body's cells cannot use insulin effectively. Diabetic foot is one of the chronic complications of diabetes mellitus (DM). Diabetic foot begins with hyperglycemia which causes abnormalities in neuropathy and blood vessels, causing infection. To determine the proportion of body mass index in patients with diabetes mellitus, to determine the prevalence of diabetic feet and non-foots. The research design used in this study is observational analytic. There is a relationship between body mass index and the risk of diabetic foot in type 2 DM patients at Royal Prima Hospital. Prevalence of body mass index 23. 0 in DM Type 2 at Royal Prima Hospital Medan in 2018-2020 reached 70%. The prevalence of diabetic foot in Type 2 DM at the Royal Prima Hospital Medan in 2018-2020 reached 54%.

2015 ◽  
Vol 162 (9) ◽  
pp. 610 ◽  
Author(s):  
Pierluigi Costanzo ◽  
John G.F. Cleland ◽  
Pierpaolo Pellicori ◽  
Andrew L. Clark ◽  
David Hepburn ◽  
...  

2001 ◽  
Vol 2 (2) ◽  
pp. 55
Author(s):  
K.M. Yafasov ◽  
S.I. Ismailov ◽  
N.Z. Sirozhiddinova ◽  
N.V. Dubyanskaya ◽  
Yu.V. Dubyanskaya

1997 ◽  
Vol 13 (5) ◽  
pp. 200-205
Author(s):  
Julie C Oki ◽  
Alexander Tal ◽  
Leland Graves ◽  
William L Isley

Objective: To determine characteristics predictive of response in patients with Type 2 diabetes mellitus (Type 2 DM) who demonstrate good or poor blood glucose control while receiving bedtime insulin with daytime sulfonylurea (BIDS) therapy. Methods: A retrospective chart review of patients with Type 2 DM receiving BIDS therapy was performed. The criterion for responders was the mean of two consecutively obtained glycosylated hemoglobin (Hb) concentrations being less than or equal to 10.2% (HbA1c ≤7.0%). Setting: A university-affiliated diabetes specialty clinic staffed consistently by a pharmacist diabetes educator, four endocrinologists, and a pharmacotherapy specialist. Patients: Thirty-one patients with Type 2 DM who were predominantly African-American and women who had documented regular follow-up examinations for more than 12 months while receiving BIDS therapy. Data Collection and Measurements: Gender, ethnicity, height, weight, calculated body mass index, age of onset of diabetes mellitus, duration of diabetes mellitus before BIDS therapy, pre-BIDS treatment regimen, dosages of NPH insulin and glyburide, glycosylated Hb concentration, fasting blood glucose concentration, and duration of BIDS therapy were recorded. Results: There were no differences in age of onset of diabetes mellitus, duration of diabetes mellitus before BIDS was initiated, duration of therapy with BIDS, or baseline glycosylated Hb concentration between responders (n = 15) and nonresponders (n = 16). Patients in the responder group weighed less, had a lower body mass index, required smaller dosages of both glyburide and NPH insulin, and achieved a lower fasting blood glucose concentration. Conclusions: In this study population, with the exception of body mass index, there was no difference in suggested clinical characteristics of response between responders and nonresponders.


2021 ◽  
Vol 8 ◽  
Author(s):  
Lemma Demissie Regassa ◽  
Assefa Tola ◽  
Yohanes Ayele

Background: Cardiovascular disease (CVD) is the most prevalent complication and the leading cause of death among patients with diabetes mellitus (DM). Type 2 diabetes mellitus (T2DM) patients have a 2- to 4-fold increased risk of CVD. There is a scarcity of data about the magnitude of CVD among patients with diabetes in Ethiopia. This study aimed to assess the prevalence and associated factors of CVD among T2DM patients at selected hospitals of Harari regional state of Ethiopia.Methods: This hospital-based retrospective data review was conducted among T2DM patients on follow-up in the diabetes clinics of selected hospitals of Harari regional state. The records of T2DM patients who have been diagnosed between January 1, 2013, and December 31, 2017, were reviewed from March to April 2018. Data were collected by using structured checklists from all necessary documents of T2DM patients. Statistical analysis was done using STATA 14.1. Bivariate and multivariate logistic regressions were used to identify factors associated with CVD.Result: The records of 454 T2DM patients were extracted from three government hospitals in Harari regional state. Their age was ranging from 15 to 86 years with a mean age (±SD) of 45.39 (14.76). The overall prevalence of CVD among T2DM patients was 42.51%, composed of hypertensive heart diseases (38.99%), heart failure (6.83%), and stroke (2.20%). The final multivariate logistic regression model revealed that age older than 60 years [adjusted odds ratio (AOR) = 3.22; 95% CI: 1.71–6.09], being physically inactive (AOR = 1.45; 95 CI: 1.06–2.38), drinking alcohol (AOR = 2.39; 95% CI: 1.17–6.06), hypertension (AOR = 2.41; 95% CI: 1.52–3.83), body mass index >24.9 kg/m2 (AOR = 1.81; 95% CI: 1.07–3.07), and experiencing microvascular diabetic complications (AOR = 3.62; 95% CI: 2.01–6.53) were significantly associated with the odds of having CVD.Conclusion: The prevalence of CVD was high and associated with advanced age, physical inactivity, drinking alcohol, higher body mass index, hypertension, and having microvascular complications. Health care workers should educate T2DM patients about healthy lifestyles like physical activity, weight reduction, blood pressure control, and alcohol secession, which can reduce the risk of CVD.


2011 ◽  
pp. 25-30
Author(s):  

Objectives: Vascular Doppler ultrasound is a non-invasive technique to rapidly detect lesions of the vessels in the lower extremities with high accuracy. The use of this technique for detecting early vascular damages in patients with diabetes mellitus (DM) type 2 could help preventing major vascular complications caused by this disease. Materials and Method: This descriptive, cross-sectional study included 31 patients with type 2 DM who were treated in Endocrinology - Neurology - Respiratory Department, Hue Central Hospital between March and August 2011. All patients were undergone clinical and biochemical examinations, and Doppler ultrasound for detection of arterial lesions in their lower extremities. Results: Most patients had high intima media thickness (IMT) (77.42%), and all of them suffered from hypertension concomitant, with the rate of atherosclerotic plaque accounted for 35.48%. No one experienced arterial stenosis >50% and arterial occlusions, but the peak systolic velocities were significantly higher in patients with atherosclerotic plaques than those without atherosclerotic plaques. Conclusion: Vascular Doppler ultrasound should be used as routine test for early detection of arterial lesions in patients with type 2 DM.


2020 ◽  
Vol 20 (4) ◽  
pp. 584-590 ◽  
Author(s):  
Shima Fathi ◽  
Shiva Borzouei ◽  
Mohammad Taghi Goodarzi ◽  
Jalal Poorolajal ◽  
Fatemeh Ahmadi-Motamayel

Background: Diabetes Mellitus (DM) is a progressive metabolic disorder. Objective: The aim of this study was to investigate the relationship between antioxidant and oxidative stress markers in the saliva of patients with type 2 DM and a healthy control group. Methods: In this study, 20 patients with diabetes and 20 healthy individuals were evaluated. Salivary antioxidants markers consisted of total antioxidant capacity (TAC), uric acid (UA), peroxidase and catalase. Oxidative stress markers included total oxidant status (TOS), malondealdehyde (MDA) and total thiol (SH). Sialochemical analysis was performed with spectrophotometric assay. All the statistical analyses were conducted using STATA software. Results: TAC decreased significantly in patients with diabetes. Although salivary UA and peroxidase were lower in patients with diabetes compared to the control group, the difference was not significant. Salivary catalase in patients with diabetes was significantly lower than that in the control group. MDA and TOS exhibited significantly higher levels in type 2 DM. SH levels were slightly higher in DM. Conclusions: According to the results of the present study, there were some changes in the salivary levels of some antioxidants and oxidative stress markers in patients with type 2 DM and could be measured as an indicator of serum changes..


Sign in / Sign up

Export Citation Format

Share Document